Glucose, blood pressure, and lipid control in older people with and without diabetes mellitus: The Cardiovascular Health Study

Journal of the American Geriatrics Society

Volumn 50, Issue 3, 2002, Pages 416-423

  Smith, Nicholas L ^a   Savage, Peter J ^a   Heckbert, Susan R ^a   Barzilay, Joshua I ^b   Bittner, Vera A ^c   Kuller, Lewis H ^d   Psaty, Bruce M ^e  

^a DIVISION OF REPRODUCTIVE BIOLOGY   (United States)

^b UNIVERSITY OF LONDON   (United Kingdom)

^c RESEARCH AND DEVELOPMENT   (Australia)

^d College of Chemistry and Molecular Engineering ^*  (China)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes mellitus; Dyslipidemia; Hypertension; Older; Risk factor control

Indexed keywords

ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; CHOLESTEROL; GLUCOSE;

AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; PREVALENCE; SYSTOLIC BLOOD PRESSURE;

AGE FACTORS; AGED; BLOOD GLUCOSE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; HUMANS; MALE; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0036122419     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1532-5415.2002.50103.x     Document Type: Article

References (41)

1. Effect of diabetes mellitus on short- and long-term mortality rates of patients with acute myocardial infarction: A statewide study
2. Stroke in patients with diabetes. The Copenhagen Stroke Study
3. Risk factors for sudden coronary death in the United States
4. Sudden death, impaired glucose tolerance, and diabetes in Japanese American men
5. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): Prospective observational study
6. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
7. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
8. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
9. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
10. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
11. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
12. Some answers, more controversy, from UKPDS. United Kingdom Prospective Diabetes Study
13. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus
14. Standards of medical care for patients with diabetes mellitus
15. Treatment of hypertension in diabetes
16. Management of dyslipidemia in adults with diabetes
17. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure
18. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
19. Aspirin therapy in diabetes
20. The Cardiovascular Health Study: Design and rationale
21. Laboratory methods and quality assurance in the Cardiovascular Health Study
22. Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study
23. Assessing the use of medications in the elderly: Methods and initial experience in the Cardiovascular Health Study
24. Validation of two methods of data collection of self-reported medicine use among the elderly
25. Temporal patterns of antihypertensive medication use among older adults, 1989 through 1992. An effect of the major clinical trials on clinical practice?
26. Antidiabetic treatment trends in a cohort of elderly people with diabetes. The cardiovascular health study, 1989-1997
27. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP)
28. The diastolic blood pressure in systolic hypertension
29. Cost-effectiveness of the lower treatment goal (of JNC VI) for diabetic hypertensive patients
30. The effect of angiotensin-convertingenzyme inhibition on diabetic nephropathy
31. Effect of antihypertensive therapy on the kidney in patients with diabetes: A meta-regression analysis
32. Effects of an angiotensin-converting-enzyme inhibitor, ramipril on cardiovascular events in high-risk patients
33. The effect of nisoldipine compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension
34. Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM
35. Rationale and design for the Antihypertensive and L0ipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
36. Baseline chatacteristics of the diabetic participants in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
37. Aspirin as a therapeutic agent in cardiovascular disease: A statement for healthcare professionals from the American Heart Association
38. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991
39. Treatment and control of hypercholesterolemia and hypertension in persons with and without diabetes
40. Lipoprotein lipids in older people. Results from the Cardiovascular Health Study
41. Time trends in the use of cholesterol-lowering agents in older adults: The Cardiovascular Health Study